taurine has been researched along with Chronic Kidney Diseases in 5 studies
Excerpt | Relevance | Reference |
---|---|---|
"Amelioration of both oxidative and inflammation status after cholesterol lowering treatment in CKD might be mediated by restoration of antioxidant taurine concentrations during therapy (from 51." | 5.20 | Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: relationship with oxidative stress improvement. ( Carru, C; Mangoni, AA; Sanna, M; Satta, AE; Sotgia, S; Zinellu, A, 2015) |
" L-glutamine supplementation failed to rectify taurine biosynthesis or CSAD protein expression, but worsened CKD (proteinuria in NxT 12." | 4.02 | Hepatic cysteine sulphinic acid decarboxylase depletion and defective taurine metabolism in a rat partial nephrectomy model of chronic kidney disease. ( Abbasian, N; Bevington, A; Brown, J; Bursnall, D; Ghaderi-Najafabadi, M; Pawluczyk, I; Seymour, AM; Watson, E; Yu Si, L, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Sengupta, P | 1 |
Biswas, S | 1 |
Roy, T | 1 |
Abbasian, N | 1 |
Ghaderi-Najafabadi, M | 1 |
Watson, E | 1 |
Brown, J | 1 |
Yu Si, L | 1 |
Bursnall, D | 1 |
Pawluczyk, I | 1 |
Seymour, AM | 1 |
Bevington, A | 1 |
Chen, DQ | 1 |
Cao, G | 1 |
Chen, H | 1 |
Argyopoulos, CP | 1 |
Yu, H | 1 |
Su, W | 1 |
Chen, L | 1 |
Samuels, DC | 1 |
Zhuang, S | 1 |
Bayliss, GP | 1 |
Zhao, S | 1 |
Yu, XY | 1 |
Vaziri, ND | 1 |
Wang, M | 1 |
Liu, D | 1 |
Mao, JR | 1 |
Ma, SX | 1 |
Zhao, J | 1 |
Zhang, Y | 1 |
Shang, YQ | 1 |
Kang, H | 1 |
Ye, F | 1 |
Cheng, XH | 1 |
Li, XR | 1 |
Zhang, L | 1 |
Meng, MX | 1 |
Guo, Y | 1 |
Zhao, YY | 1 |
Zinellu, A | 1 |
Sotgia, S | 1 |
Mangoni, AA | 1 |
Sanna, M | 1 |
Satta, AE | 1 |
Carru, C | 1 |
Davies, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease[NCT05719714] | Phase 1/Phase 2 | 60 participants (Anticipated) | Interventional | 2023-11-01 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for taurine and Chronic Kidney Diseases
Article | Year |
---|---|
Veterinary clinical nutrition: success stories: an overview.
Topics: Animal Nutritional Physiological Phenomena; Animals; Calculi; Cardiomyopathies; Cardiomyopathy, Dila | 2016 |
2 trials available for taurine and Chronic Kidney Diseases
Article | Year |
---|---|
Comparative Study to Evaluate the Effect of Low-Protein Diet Supplementation with Taurine and N-Acetylcysteine, N-Acetylcysteine and Pyridoxamine Dihydrochloride in Preventing the Progression of Chronic Renal Failure in Patients with Non-Diabetic Kidney D
Topics: Acetylcysteine; Adult; Aged; Diet, Protein-Restricted; Dietary Supplements; Disease Progression; Fem | 2022 |
Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: relationship with oxidative stress improvement.
Topics: Aged; Allantoin; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Res | 2015 |
2 other studies available for taurine and Chronic Kidney Diseases
Article | Year |
---|---|
Hepatic cysteine sulphinic acid decarboxylase depletion and defective taurine metabolism in a rat partial nephrectomy model of chronic kidney disease.
Topics: Animals; Carboxy-Lyases; Cysteine Dioxygenase; Dietary Supplements; Disease Models, Animal; Glutamin | 2021 |
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan.
Topics: Acetylcarnitine; Animals; Canavanine; Carnitine; Case-Control Studies; Disease Models, Animal; Disea | 2019 |